Cancer News and Research

Latest Cancer News and Research

Gefitinib (Iressa) could reduce the size of breast cancer tumours

Giving women with early breast cancer a drug called gefitinib (Iressa) before surgery could reduce the size of their tumours, suggests a randomised trial published online today by The Lancet Oncology.

17 May 2005

Rifaximin is effective in preventing attacks of diarrhea

An antibiotic can be safely used to prevent attacks of diarrhea that plague millions of globe-trotting vacationers and business travelers, a Houston research team reports this week in the Annals of Internal Medicine.

17 May 2005

Vitamin D, taxotere combination promising for advanced prostate cancer

Results of a new study strongly suggest that DN-101, a new high-dose calcitriol pill designed specifically as a cancer therapy, given in combination with docetaxel (Taxotere) extends the lives of men with advanced prostate cancer.

17 May 2005

Researchers create the first mouse model that develops a lymphoma the same way that humans do

This advancement has the potential to significantly speed the development of new, improved therapies for diffuse large B cell lymphoma (DLBCL), the most common type of human B cell lymphoma. Human B cell lymphomas cause 85 percent of non-Hodgkin's lymphomas, the sixth leading cause of cancer deaths in the United States.

17 May 2005

SU11248 drug show promise against neuroendocrine tumors-stubborn cancers that respond poorly to chemotherapy

A unique, targeted anti-cancer drug appears to show promise against neuroendocrine tumors-stubborn cancers that have traditionally responded poorly to chemotherapy, according to research findings announced at the 2005 Annual Meeting of the American Society of Clinical Oncology (ASCO).

17 May 2005

Patients with suspicious axillary lymph nodes in their breasts should first undergo ultrasound-guided fine-needle aspiration to avoid unnecessary surgery

Currently, breast cancer patients undergo axillary lymph node dissection for accurate staging and control of the cancer. In many cases, this major procedure can be replaced by sentinel lymph node biopsy, which is a more simple and less invasive surgical procedure, but many still have to undergo axillary dissection after the sentinel lymph node biopsy.

17 May 2005

Whole-body MRI takes less than twenty minutes to accurately scan a patient’s entire body for cancer spread to the bone

Whole-body MRI with an automatic moving table is effective for evaluating the entire skeleton in patients with suspected bone metastasis (cancer that has spread to the bone from other parts of the body) in a single imaging scan-and it only takes between 15 and 18 minutes, say two different European studies.

17 May 2005

MDCT overtakes ventilation-perfusion lung scan for diagnosing pulmonary embolism

MDCT pulmonary angiography is replacing the ventilation-perfusion lung scan to diagnose suspected pulmonary embolism in hospitalized patients, say researchers from Rhode Island Hospital in Providence.

17 May 2005

Antibody combined with cancer drug shows promise against breast tumors

An antibody that targets the blood vessels nourishing tumors significantly reduced breast cancer formation and growth in mice when combined with a current cancer drug, according to researchers at UT Southwestern Medical Center.

16 May 2005

Deletion on chromosome 11q may guide decision to use chemotherapy for neuroblastoma

When genes are deleted on a particular section of chromosome 11, the result is an aggressive form of the childhood cancer neuroblastoma. A new study suggests that detecting this genetic deletion during the initial evaluation of children with neuroblastoma may indicate to physicians that they should recommend a more aggressive regimen of chemotherapy to fight the cancer.

16 May 2005

Drugs that block the enzyme Odc prevent the onset of cancers

The drug DFMO prevents cancer in laboratory models of lymphoma but fails to kill existing cancerous cells that have lost the ability to self-destruct, according to investigators at St. Jude Children's Research Hospital.

16 May 2005

Statin chemoprevention with minimal surveillance could prevent 96 percent of colon cancers

Ulcerative colitis affects about one out of every 2,000 Americans, and after living with the disease for 30 years, nearly 22 percent of those people will develop colon cancer.

16 May 2005

Identifying high-risk prostate cancer means more prudent treatment decisions

While prostate cancer is a very common diagnosis, it is a deadly disease in relatively few men. One in 6 men will develop prostate cancer during his lifetime. However, of these, only one in 10 cases will be life-threatening.

16 May 2005

High-risk for melanoma patients no more likely to take proper precautions in the sun

Those considered high-risk for melanoma--the most dangerous form of skin cancer--are no more likely to sunbathe protected than those who are unaware of their risk, according to a new study conducted by McGill University Health Centre (MUHC) researchers.

16 May 2005

Combined MRI and mammography more effective at detecting breast cancer in high risk women

Annual screening, using magnetic resonance imaging (MRI) and X-ray mammography, is the best way to detect breast cancer in women that have a high genetic risk of the disease, according to a study published online by The Lancet.

16 May 2005

Statins appear to lessen chance of developing breast cancer

According to a new study women who are taking the cholesterol-lowering drugs called statins, such as Lipitor or Mevacor, appear to have much less chance of developing breast cancer.

16 May 2005

New study demonstrates high rates of tumor death in patients receiving regimen

A new pilot study suggests that treating soft-tissue sarcoma with a new regimen of intense chemotherapy and a short course of radiation before surgery may be beneficial. About 41 percent of study participants were found to have complete tumor death at the time of surgery.

16 May 2005

Bevacizumab (Avastin) combined with low-dose chemotherapy slows ovarian cancer

A targeted cancer drug given with low-dose chemotherapy shrank ovarian tumors and slowed progression of ovarian cancer in patients with recurrent disease, according to research findings presented by Agustin Garcia, M.D., principal investigator of the study and Director of Breast Cancer Research at the Women's Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center.

16 May 2005

More health benefits from green tea

Green tea appears to protect against cancer by affecting a "promiscuous" protein that pharmaceutical experts are already targeting in an effort to develop a new drug to stop the disease, scientists at the University of Rochester Medical Center have found.

16 May 2005

Hour of day and time of year has significant impact on blood pressure levels

The odds of measuring an elevated blood pressure can vary by as much as 40 percent depending on the time of day and time of year, according to researchers from the Center for Health Research and Rural Advocacy at Geisinger Health System in Pennsylvania. They recommend that clinicians anticipate changes in blood pressure due to these temporal factors when diagnosing and considering treatment options for their patients.

16 May 2005

Cancer News and Research

Latest Cancer News and Research

Gefitinib (Iressa) could reduce the size of breast cancer tumours

Rifaximin is effective in preventing attacks of diarrhea

Vitamin D, taxotere combination promising for advanced prostate cancer

Researchers create the first mouse model that develops a lymphoma the same way that humans do

SU11248 drug show promise against neuroendocrine tumors-stubborn cancers that respond poorly to chemotherapy

Patients with suspicious axillary lymph nodes in their breasts should first undergo ultrasound-guided fine-needle aspiration to avoid unnecessary surgery

Whole-body MRI takes less than twenty minutes to accurately scan a patient’s entire body for cancer spread to the bone

MDCT overtakes ventilation-perfusion lung scan for diagnosing pulmonary embolism

Antibody combined with cancer drug shows promise against breast tumors

Deletion on chromosome 11q may guide decision to use chemotherapy for neuroblastoma

Drugs that block the enzyme Odc prevent the onset of cancers

Statin chemoprevention with minimal surveillance could prevent 96 percent of colon cancers

Identifying high-risk prostate cancer means more prudent treatment decisions

High-risk for melanoma patients no more likely to take proper precautions in the sun

Combined MRI and mammography more effective at detecting breast cancer in high risk women

Statins appear to lessen chance of developing breast cancer

New study demonstrates high rates of tumor death in patients receiving regimen

Bevacizumab (Avastin) combined with low-dose chemotherapy slows ovarian cancer

More health benefits from green tea

Hour of day and time of year has significant impact on blood pressure levels

Understanding the DNA Damage Response in Innate Immunity eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in